Literature DB >> 21686696

Intravenous immunoglobulin therapy in proximal diabetic neuropathy.

Yuichi Kawagashira1, Hirohisa Watanabe, Yumiko Oki, Masahiro Iijima, Haruki Koike, Naoki Hattori, Masahisa Katsuno, Fumiaki Tanaka, Gen Sobue.   

Abstract

A 57-year-old man with type 2 diabetes mellitus for 10 years showed progressive loss of muscle strength in both legs, pain and muscle atrophy in the femoral region and significant weight loss. On admission, he could not stand alone and used a wheelchair. He also complained of severe pain in the lower extremities. He was diagnosed with proximal diabetic neuropathy (PDN) by characteristic clinical and electrophysiological features. Intravenous immunoglobulin therapy (IVIg 0.4 g/kg×5 days) markedly reduced the severe pain and muscle weakness in the legs. Eventually, pain assessed by the Visual Analogue Scale was relieved by 80% and muscle strength was also well recovered, thereby enabling the patient to walk with a cane. The present case suggests that IVIg therapy may be effective for the relief of pain in PDN.

Entities:  

Year:  2009        PMID: 21686696      PMCID: PMC3028441          DOI: 10.1136/bcr.08.2008.0656

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain.

Authors:  A M Kelly
Journal:  Emerg Med J       Date:  2001-05       Impact factor: 2.740

2.  Intravenous immunoglobulin therapy for diabetic amyotrophy.

Authors:  T Ogawa; T Taguchi; Y Tanaka; K Ikeguchi; I Nakano
Journal:  Intern Med       Date:  2001-04       Impact factor: 1.271

3.  Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy.

Authors:  P J Dyck; J E Norell; P J Dyck
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

4.  Epineurial microvasculitis in proximal diabetic neuropathy.

Authors:  J G Llewelyn; P K Thomas; R H King
Journal:  J Neurol       Date:  1998-03       Impact factor: 4.849

5.  Diabetic amyotrophy in an adolescent responsive to intravenous immunoglobulin.

Authors:  Jose Americo Fernandes Filho; Brandon M Nathan; Mark R Palmert; Bashar Katirji
Journal:  Muscle Nerve       Date:  2005-12       Impact factor: 3.217

6.  Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy).

Authors:  P Kelkar; M Masood; G J Parry
Journal:  Neurology       Date:  2000-07-12       Impact factor: 9.910

Review 7.  Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment.

Authors:  P James B Dyck; Anthony J Windebank
Journal:  Muscle Nerve       Date:  2002-04       Impact factor: 3.217

8.  Nerve biopsy findings in different patterns of proximal diabetic neuropathy.

Authors:  G Said; C Goulon-Goeau; C Lacroix; A Moulonguet
Journal:  Ann Neurol       Date:  1994-05       Impact factor: 10.422

9.  The Bruns-Garland syndrome (diabetic amyotrophy). Revisited 100 years later.

Authors:  R J Barohn; Z Sahenk; J R Warmolts; J R Mendell
Journal:  Arch Neurol       Date:  1991-11

10.  Diabetic peripheral neuropathy: a clinicopathologic and immunohistochemical analysis of sural nerve biopsies.

Authors:  D S Younger; G Rosoklija; A P Hays; W Trojaborg; N Latov
Journal:  Muscle Nerve       Date:  1996-06       Impact factor: 3.217

View more
  1 in total

Review 1.  The Production Processes and Biological Effects of Intravenous Immunoglobulin.

Authors:  Ana Filipa Barahona Afonso; Cristina Maria Pires João
Journal:  Biomolecules       Date:  2016-03-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.